Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-7,426
Closed -$589K – 1195
2022
Q4
$589K Buy
+7,426
New +$523K 0.02% 639
2022
Q3
– Sell
-8,222
Closed -$451K – 1501
2022
Q2
$451K Buy
+8,222
New +$476K 0.01% 884
2021
Q3
– Sell
-6,500
Closed -$263K – 1148
2021
Q2
$263K Buy
+6,500
New +$269K 0.01% 1134

Other funds holding ACLS

Ergoteles's ACLS Position: Q1 2023 in Review

Ergoteles sold out of Axcelis (ACLS) in Q1 2023, closing a stake of 7,426 shares — an estimated $589K sold.

Ergoteles first reported a position in ACLS in Q2 2021 and held it in 3 quarters. The position peaked at $589K in Q4 2022. 378 funds tracked by Wall St. Rank hold ACLS as of Q1 2023.

  • Ergoteles reported no remaining Axcelis position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 7,426 Axcelis shares in Q1 2023, an estimated $589K.
  • Ergoteles first reported a position in Axcelis in Q2 2021 and held it in 3 quarters.
  • Ergoteles's Axcelis position peaked at $589K in Q4 2022.
  • 378 funds tracked by Wall St. Rank held Axcelis as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.